← Back to patent-cliff list
CAS 1021869-28-2
methyl (E)-3-(dimethylamino)-2-(1H-1,2,3-triazol-1-yl)acrylate
Codes: MOLID-004
Application context (from source-drug indications)
Chronic renal impairmentMolidustat SodiumAnaemiaMolidustat SodiumKidney diseaseMolidustat Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Molidustat Sodium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1H-1,2,3-triazole→methyl 2-bromoacetate→methyl 2-(1H-1,2,3-triazol-1-yl)acetate→methyl (E)-3-(dimethylamino)-2-(1H-1,2,3-triazol-1-yl)acrylate→4-(6-hydrazinylpyrimidin-4-yl)morpholine→4,6-dichloropyrimidine→4-chloro-6-hydrazinylpyrimidine→morpholine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.